VNET:NASDAQVNET Group, Inc. Analysis
Data as of 2026-09-01 - not real-time
$6.06
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind VNET Group, Inc. is bearish at $6.06, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 21.1%. RSI sits at 35.8, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at $6.02 up to resistance at $7.96.
On valuation the read is undervalued — earnings multiple of 39.9 versus a 35.8 sector average, above the peer group. Analyst price targets sit 126.8% above the current price. Revenue is growing at 14.2% on a -6.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 89.2%, a beta of 2.44 and a maximum drawdown of 56.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 1/10 conviction over the longer horizon.
On valuation the read is undervalued — earnings multiple of 39.9 versus a 35.8 sector average, above the peer group. Analyst price targets sit 126.8% above the current price. Revenue is growing at 14.2% on a -6.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 89.2%, a beta of 2.44 and a maximum drawdown of 56.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 1/10 conviction over the longer horizon.
Top Market Events
BEIJING AP — BEIJING AP — VNET Group, Inc.Updated Aug 4, 2026 0 BEIJING, Aug. 4, 2026 /PRNewswire/ -- VNET Group, Inc. Nasdaq: VNET "VNET" or the "Company" , a...BEIJING, Aug. 18, 2026 /PRNewswire/ -- VNET Group, Inc. Nasdaq: VNET "VNET" or the "Company" , a leading carrier- and...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 9.12
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 39.9 versus sector average of 35.8
- Trading below the 200-day average of 9.12
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 39.9 versus sector average of 35.8
- Negative profit margin of -6.2%
- Analyst targets imply +126.8% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth14.20%
Profit Margin-6.24%
P/E Ratio39.9
ROE-4.70%
ROA1.17%
Debt/Equity309.21
P/B Ratio2.8
Op. Cash Flow$1.7B
Free Cash Flow$-3814723584
Industry P/E35.8
Technical Analysis
TrendBearish
RSI35.8
Support$6.02
Resistance$7.96
MA 20$7.01
MA 50$7.42
MA 200$9.12
MACDBearish
VolumeIncreasing
Fear & Greed Index93.27
Valuation
Fair Value$13.43
Target Price$13.74
Upside/Downside126.79%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta2.44
Volatility89.16%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.